Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.051 | 0.3 |